TrialWorld journal of gastroenterology2017

New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial.

Jae Yoon Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.